Gordon A. Gardiner - Nov 24, 2021 Form 4/A - Amendment Insider Report for CytoDyn Inc. (CYDY)

Role
Director
Signature
/s/ Antonio Migliarese, Attorney-In-Fact Signature of Reporting Person
Stock symbol
CYDY
Transactions as of
Nov 24, 2021
Transactions value $
$0
Form type
4/A - Amendment
Date filed
11/30/2021, 05:31 PM
Date Of Original Report
Nov 29, 2021
Previous filing
Oct 20, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYDY Non-qualified Stock Option Disposed to Issuer -225K -100% 0 Nov 24, 2021 Common Stock 225K $1.39 Direct F1
transaction CYDY Non-qualified Stock Option Award +93.8K 93.8K Nov 24, 2021 Common Stock 93.8K $1.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Gordon A. Gardiner is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The term of the Reporting Person's Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended (the "2012 Plan")) as a director of the Issuer ended as of the conclusion of the Issuer's 2021 Annual Meeting of Stockholders on November 24, 2021. Effective immediately prior to the end of the Reporting Person's Continuous Service, the stock option granted to the Reporting Person under the 2012 Plan was amended to (a) vest and become immediately exercisable, to the extent it would have become vested on December 1, 2021, with the balance of the unvested portion of such option immediately forfeited, and (b) cause the option to remain exercisable through the original expiration date instead of terminating 90 days following the end of the Reporting Person's Continuous Service.